Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resiquimod Gel for Common Warts
NCT00115141Phase 2Completed
- Sponsor
- Graceway Pharmaceuticals
- Start
- Apr 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of resiquimod in common warts, sponsored by Graceway Pharmaceuticals. Started Apr 2004; status: completed.
02
Drugs
resiquimod
03
Conditions
common warts
Beyond the preview
Go deeper on NCT00115141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115141.